← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2019Last known activity
Sep 20, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 4 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT05543837CollaboratorPhase 2Sep 20, 2022
- NCT04381858Lead sponsorPhase 3May 6, 2020
- NCT04391127Lead sponsorPhase 3May 4, 2020
- NCT04545892CollaboratorPhase 1Dec 1, 2019
Details
- Last known activity
- Sep 20, 2022